ALPS Advisors’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-5,629
| Closed | -$113K | – | 993 |
|
|
2023
Q3 | $113K | Buy |
5,629
+42
| +0.8% | +$844 | ﹤0.01% | 968 |
|
|
2023
Q2 | $150K | Buy |
+5,587
| New | +$150K | ﹤0.01% | 981 |
|
|
2020
Q4 | – | Sell |
-6,247
| Closed | -$1.37M | – | 863 |
|
|
2020
Q3 | $1.37M | Sell |
6,247
-403
| -6% | -$88.3K | 0.02% | 287 |
|
|
2020
Q2 | $1.89M | Buy |
+6,650
| New | +$1.89M | 0.03% | 244 |
|
|
2016
Q2 | – | Sell |
-2,679
| Closed | -$358K | – | 630 |
|
|
2016
Q1 | $358K | Sell |
2,679
-459
| -15% | -$61.3K | ﹤0.01% | 572 |
|
|
2015
Q4 | $624K | Sell |
3,138
-587
| -16% | -$117K | 0.01% | 254 |
|
|
2015
Q3 | $5.88K | Buy |
3,725
+1,363
| +58% | +$2.15K | 0.01% | 245 |
|
|
2015
Q2 | $964K | Buy |
2,362
+1,182
| +100% | +$482K | 0.01% | 215 |
|
|
2015
Q1 | $542K | Buy |
+1,180
| New | +$542K | ﹤0.01% | 322 |
|